Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of -628.02% is 9574% below its 5-year average of -6.49%, near the high end of its 5-year range (-3925.65%–99.70%).
590.34% below its 12-month average of -90.97%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
-628.02%
GROSS MARGIN AVG TTM
-90.97%
GROSS MARGIN AVG 3Y
-26.82%
GROSS MARGIN AVG 5Y
-6.49%
GROSS MARGIN AVG 10Y
-45.90%
GROSS MARGIN AVG 15Y
-51.24%
GROSS MARGIN AVG 20Y
-29.62%
CURRENT VS TTM AVG
-590.34%
CURRENT VS 3Y AVG
-2241.66%
CURRENT VS 5Y AVG
-9573.50%
CURRENT VS 10Y AVG
-1268.21%
CURRENT VS 15Y AVG
-1125.54%
CURRENT VS 20Y AVG
-2020.10%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-1617.69%
vs the sector median at left
GeoVax Labs, Inc.
Market Cap
$2.13M
Gross Margin
-628.02%
TTM Avg
-90.97%
3Y Avg
-26.82%
5Y Avg
-6.49%
Market Cap
$2.14M
Gross Margin
59.72%
TTM Avg
60.22%
3Y Avg
60.72%
5Y Avg
66.21%
Market Cap
$2.32M
Gross Margin
63.43%
TTM Avg
61.72%
3Y Avg
62.82%
5Y Avg
60.98%
Market Cap
$1.88M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.88M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Gross Margin
80.40%
TTM Avg
59.71%
3Y Avg
-452.13%
5Y Avg
-301.42%
Market Cap
$2.38M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.38M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | $2.13M | -628.02% | -90.97% | -26.82% | -6.49% |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | 59.72% | 60.22% | 60.72% | 66.21% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | 63.43% | 61.72% | 62.82% | 60.98% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Onconetix, Inc. (ONCO)vs › | $2.37M | 80.40% | 59.71% | -452.13% | -301.42% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.38M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | 66.25% | 56.00% | 15.40% | 30.93% |
Gross Margin
-628.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -454.86% |
| 2025-03-31 | -227.12% |
| 2024-12-31 | 97.50% |
| 2024-09-30 | -165.39% |
| 2024-06-30 | -1322.41% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 84.95% |
| 2021-12-31 | 99.70% |
| 2021-09-30 | -3925.65% |
| 2021-06-30 | -944.86% |
| 2021-03-31 | -445.92% |
| 2020-12-31 | -200.99% |
| 2020-09-30 | -0.31% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | -62.41% |
| 2019-09-30 | -40.35% |
| 2019-06-30 | -114.93% |
| 2019-03-31 | -52.57% |
| 2018-12-31 | -54.28% |
| 2018-09-30 | -59.64% |
| 2018-06-30 | -299.08% |
| 2018-03-31 | -120.06% |
| 2017-12-31 | -150.42% |
| 2017-09-30 | -100.89% |
| 2017-06-30 | -47.19% |
| 2017-03-31 | -86.42% |
| 2016-12-31 | -158.01% |
| 2016-09-30 | -55.40% |
| 2016-06-30 | -139.10% |
| 2016-03-31 | -812.51% |
| 2015-12-31 | -228.83% |
| 2015-09-30 | -307.01% |
| 2015-06-30 | -438.17% |
| 2015-03-31 | -290.27% |
| 2014-12-31 | -109.97% |
| 2014-09-30 | -32.11% |
| 2014-06-30 | -186.08% |
| 2014-03-31 | -156.04% |
| 2013-12-31 | -243.71% |
| 2013-09-30 | 12.46% |
| 2013-06-30 | -25.28% |
| 2013-03-31 | -10.66% |
| 2012-12-31 | -42.97% |
| 2012-09-30 | 5.69% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-09-30 | 0.00% |
| 2004-06-30 | 0.00% |
| 2004-03-31 | 0.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 64.79% |
| 2002-06-30 | 13.27% |
| 2002-03-31 | -230.83% |
| 2001-12-31 | -26.20% |
| 2001-09-30 | 12.04% |
